Dr. Tom O'Brien Genentech, USA

Tom O'Brien, PhD, is a member of the small molecule discovery group at Genentech. Prior to this he was a Senior Scientist at Sunesis Pharmaceuticals. Dr. O'Brien's research has focused on identifying small molecule inhibitors that display specificity for different caspase family members. Additionally, he has played a pivotal role... read morein developing novel technologies that aid the identification and advancement of small molecule leads against a number of important therapeutic targets.